After respiratory syncytial virus (RSV) circulation was suppressed early in the COVID-19 pandemic, the number of admissions ...

Giving the respiratory syncytial virus (RSV) vaccine to pregnant women provides 81.3% protection to newborn infants, ...

Immunisation against RSV is safe and effective, but very expensive, HIQA has said. The Health Information and Quality ...

RSV can present as mild, cold-like symptoms in many children, but it is the leading cause of hospitalization in babies under 1 year, and can lead to conditions like pneumonia and bronchiolitis. While ...

Surveillance captured 16,775 RSV-associated hospitalizations/ED visits; median age was 10 months, with 41% of ...

A common seasonal virus that can cause serious illness in infants is spreading among children earlier and faster this year: Cases of respiratory syncytial virus, better known as RSV, are on the rise, ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved the monoclonal antibody clesrovimab-cfor for preventing RSV disease in babies. Unlike ...

RSV is the leading cause of hospitalization for babies under one and can lead to severe respiratory issues. New FDA-approved immunizations have been shown to significantly reduce RSV-related ...

The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 cause of hospitalization in infants. The US Food and Drug Administration ...

The Food and Drug Administration (FDA) on Monday approved the first vaccine meant to prevent infections in infants, with the new drug designed to be administered to pregnant mothers in their third ...

Add Yahoo as a preferred source to see more of our stories on Google. Mar. 18—The Washington state Department of Health (DOH) has extended the availability of respiratory syncytial virus (RSV) ...

Immunising infants to protect them from the potentially serious respiratory syncytial virus (RSV) infection is safe and ...